Skip to content

Comparison of the effect of mindfulness-based cognitive therapy(MBCT) and acceptance and commitment therapy(ACT) on epilepsy

Comparison of the effect of mindfulness-based cognitive therapy(MBCT) and acceptance and commitment therapy(ACT) on improving self-efficacy, self-esteem and quality of life in patients with focal epilepsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190205042634N1
Enrollment
36
Registered
2019-02-24
Start date
2019-03-11
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy. Epilepsy and recurrent seizures

Interventions

Intervention 1: Acceptance and Commitment therapy(ACT) and meetings that will be conducted in 8 consecutive weeks in accordance to protocol for 8 consecutive 90-minute sessions. Intervention 2: Mindfu

Sponsors

Semnan University of Medical Sciences
Lead Sponsor
Semnan University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Diagnosis of focal epilepsy by specialist physician age 18 to 30 years of patients written consent of the patient or his or her family

Exclusion criteria

Exclusion criteria: Lack of readiness of the patient or his or her family Trauma and brain lesions Other severe physical illnesses Excessive psychiatric disorders Failure to continue the treatment session

Design outcomes

Primary

MeasureTime frame
The quality of life scores obtained by the subjects in the Ver-Sherborne Quality of Life Questionnaire (SF-36), the self-efficacy scores obtained by the subjects on the self-efficacy scale of patients with epilepsy (ESE), and the self-esteem score that subjects were given in the Dignity Inventory Breathe coprasmith. Timepoint: Before the intervention, after the intervention and three months after the intervention in the follow up period. Method of measurement: ware and Sherbourne Quality of Life Questionnaire (SF-36) for Quality of Life, Self-Efficacy Scale for Epilepsy Patients (ESE), to assess self-efficacy and Cooper smith's self-esteem questionnaire for assessing self-esteem.

Secondary

MeasureTime frame
Reduce the frequency of seizure attacks. Timepoint: Three months after the intervention. Method of measurement: Redefining Epilepsy Symptoms Scale (ESS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mohammadpour

The University of Semnan

mmpour2009@gmail.com+98 41 3669 4279

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026